The Satisfaction level with Insulin Treatment in Type 1 Diabetics - Yazd Diabetes Research Center 2019

Ghadiri-Anari, Akram; Namiranian, Nasim; Mahmoudi Kohani, Hassan ali; Razavi, Roghaye; Jam Ashkezari, Saeedeh; Mozafari, Zohre; Ordooei, Mahtab

doi:10.18502/ijdo.v15i2.12965

Volume 15, Issue 2 (volume 15, number 2 2023) IJDO 2023, 15(2): 81-86 | Back to browse issues page

‎ 10.18502/ijdo.v15i2.12965

Mendeley

Zotero

RefWorks

Ghadiri-Anari A, Namiranian N, Mahmoudi Kohani H A, Razavi R, Jam Ashkezari S, Mozafari Z et al . The Satisfaction level with Insulin Treatment in Type 1 Diabetics - Yazd Diabetes Research Center 2019. IJDO 2023; 15 (2) :81-86
URL: http://ijdo.ssu.ac.ir/article-1-790-en.html

The Satisfaction level with Insulin Treatment in Type 1 Diabetics - Yazd Diabetes Research Center 2019

Akram Ghadiri-Anari

, Nasim Namiranian

, Hassan ali Mahmoudi Kohani

, Roghaye Razavi ^*

, Saeedeh Jam Ashkezari

, Zohre Mozafari

, Mahtab Ordooei

Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Abstract: (246 Views)

Objective: Diabetes is a non-communicable disease. The patient satisfaction with treatment is a key point of patient’s compliance. Definitive treatment for patients with type 1 diabetes is lifelong insulin injections, but type 1 diabetic patients are commonly in poor glycemic state due to poor compliance. Therefore, it is necessary to check insulin treatment satisfaction in this population. Therefore, the main purpose of this study was to evaluate the satisfaction of insulin treatment in patients with type 1 diabetes in Yazd.
Materials and Methods: In this cross-sectional study, 114 patients with type 1 diabetes participated. Persian version of Insulin Treatment Satisfaction Questionnaire (ITSQ) used. All analyzes were performed by SPSS 22.
Results: The overall satisfaction mean score in this study was 49.72(± 8.88). Insulin treatment satisfaction score had a significant positive correlation with BMI (P: 0.00) and age (P: 0.04). Hypoglycemic control sub-scale showed a positive correlation with BMI (P: 0.01) and age (P: 0.01). Also, inconvenience of insulin therapy regimen sub-scale showed a significant positive correlation with age (P: 0.04). Overall satisfaction and sub-groups had no significant correlation with other variables.
Conclusion: The overall satisfaction in type 1 diabetics was unacceptable. Understanding the pathogenesis of this problem could guide health care providers for better and effective management of type 1 diabetes. Also, a more comprehensive approach with consider all potentially relevant variables is necessary.

Keywords: Type 1 diabetes mellitus, Insulin, Treatment satisfaction

Full-Text [PDF 565 kb] (111 Downloads)

Type of Study: Research | Subject: Special
Received: 2023/01/8 | Accepted: 2023/04/8 | Published: 2023/06/20

References

1. Bhutani J, Bhutani S. Worldwide burden of diabetes. Indian journal of endocrinology and metabolism. 2014;18(6):868.

2. Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Fard HH, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health promotion perspectives. 2020;10(2):98-115.

3. Bromba M, Campbell F, Levy BL. The Insulin Treatment Satisfaction Questionnaire and assessment of satisfaction with a latest-generation insulin pump. European Endocrinology. 2015;11(2):67.

4. Brod M, Cobden D, Lammert M, Bushnell D, Raskin P. Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health and quality of life outcomes. 2007;5(1):1-0.

5. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health and quality of life outcomes. 2004;2:1-3. [DOI:10.1186/1477-7525-2-36]

6. Anderson RT, Skovlund SE, Marrero D, Levine DW, Meadows K, Brod M, Balkrishnan R. Development and validation of the insulin treatment satisfaction questionnaire. Clinical therapeutics. 2004;26(4):565-78.

7. Ghadiri-Anari A, Jam-Ashkezari S, Namiranian N, Biglari Abhari M. Persian version of insulin treatment satisfaction measurement; an original study. Journal of Renal Endocrinology. 2020;6:e02.

8. Cappelleri JC, Gerber RA, Kourides IA, Gelfand RA. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes care. 2000;23(12):1799-803.

9. Wilbur K, Al Hammaq AO. Validation of an arabic version of the diabetes treatment satisfaction questionnaire in Qatar. Diabetes Research and Clinical Practice. 2016;113:53-9.

10. Rubin RR, Peyrot M. Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the Inhaled Insulin Treatment Questionnaire (IITQ). Health and Quality of Life Outcomes. 2010;8(1):1-8.

11. Brod M, Christensen T, Bushnell D. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Quality of Life Research. 2007:1053-63.

12. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes care. 2002;25(3):458-63.

13. Taylor MD, Frier BM, Gold AE, Deary IJ. Psychosocial factors and diabetes‐related outcomes following diagnosis of type 1 diabetes in adults: The Edinburgh prospective diabetes study. Diabetic Medicine. 2003;20(2):135-46.